Key result
Human gamma globulin administered intramuscularly protected suckling mice against intraperitoneal MEF1 poliomyelitis virus without preventing active immunity against subsequent Lansing virus challenge.
Why the study?
Does human gamma globulin protect suckling mice against MEF1 poliomyelitis virus?
Does human gamma globulin protect suckling mice against MEF1 poliomyelitis virus?
Human gamma globulin provides passive protection against MEF1 poliomyelitis virus in suckling mice without preventing active immunity to subsequent Lansing virus challenge.
Answers are grounded in this paper and cite their sources.
Supports passive-active immunity in murine viral models; leaves open translation to human poliomyelitis prevention.
Suckling mice 5-13 days old were protected against the intraperitoneal inoculation of suckling mouse-adapted MEF1 virus by the intramuscular inoculation of human gamma globulin in amounts as small as 0.05 ml/lb 24 hours prior to the virus challenge. Human gamma globulin in an amount (0.1 ml/lb) adequate to protect against the intraperitoneal inoculation of the suckling mouse-adapted MEF1 virus did not prevent the development of active immunity against the subsequent intracerebral inoculation of Lansing virus.
No takes yet. Share an insight, caveat, or question.
Hammon et al. (1952) studied Poliomyelitis virus infection. Human gamma globulin was evaluated on Protection against intraperitoneal inoculation of MEF1 virus and development of active immunity against Lansing virus. Human gamma globulin administered intramuscularly protected suckling mice against intraperitoneal MEF1 poliomyelitis virus without preventing active immunity against subsequent Lansing virus challenge.
Synapse has enriched 10 related papers. Consider them for comparative context: